Valuation: Inventage Lab, Inc.

Market Cap	398B 287M 246M 231M 211M 398M 27.35B 400M 2.73B 1.06B 13.8B 1.08B 1.05B 45.71B	P/E 2024	-11.5x	P/E 2025	-110x
Enterprise Value	392B 283M 243M 228M 208M 393M 26.99B 395M 2.7B 1.05B 13.62B 1.06B 1.04B 45.1B	EV / Sales 2024	106x	EV / Sales 2025	356x
Free-Float	73.58%	Yield 2024 *	-	Yield 2025	-

* Estimated data More valuation ratios

Latest news : Inventage Lab, Inc.

03-15	Quratis Inc. announced that it has received KRW 10.000000167 billion in funding from Inventage Lab, Inc.	CI
03-15	Inventage Lab, Inc. announced that it has received KRW 89.99724455 billion in funding from a group of investors	CI
03-08	Inventage Lab, Inc. announced that it has received KRW 8.5 billion in funding	CI
03-05	Inventage Lab, Inc. announced that it expects to receive KRW 37.25 billion in funding from a group of investors	CI
03-05	Inventage Lab, Inc. announced that it expects to receive KRW 8.5 billion in funding	CI
03-05	Inventage Lab, Inc. announced that it expects to receive KRW 52.74724455 billion in funding from a group of investors	CI
03-05	Quratis Inc. announced that it expects to receive KRW 10.000000167 billion in funding from Inventage Lab, Inc.	CI
02-25	Inventage Lab, Inc. agreed to acquire an additional 12.79% stake in Quratis Inc. for KRW 13.5 billion.	CI
12-10	Inventage Lab Seeks Approval for Phase 2 Trial of Alopecia Drug in Australia	MT
25-09-22	Inventage Lab, Inc.(KOSDAQ:A389470) added to S&P Global BMI Index	CI
25-03-11	Inventage Lab, Inc. announced that it has received KRW 9.9999925 billion in funding from PEACE to S KOREA Co., Ltd	CI
25-03-11	Quratis Inc. announced that it has received KRW 10.0329 billion in funding from Inventage Lab, Inc.	CI
25-02-20	Quratis Inc. announced that it has received KRW 15 billion in funding from Inventage Lab, Inc.	CI

More news

Managers and Directors: Inventage Lab, Inc.

Manager	Title	Age	Since
Ju-Hee Kim CEO	Chief Executive Officer	52	2015-05-13
Byeong-Yul Jeong DFI	Director of Finance/CFO	55	-
Chan-Hee Jeon CTO	Chief Tech/Sci/R&D Officer	57	-

Director	Title	Age	Since
Ju-Hee Kim BRD	Director/Board Member	52	2015-05-13
Choong-Ho Ryu BRD	Director/Board Member	56	-
Chan-Hee Jeon BRD	Director/Board Member	57	-

More insiders

Inventage Lab Inc is a Korea-based company principally engaged in the pharmaceutical business. The Company owns the platforms applied to the development and mass production of long-acting injections and drug delivery of genetic materials. The Company is engaged in the research, manufacture and sale of human medicines used for male pattern baldness, dementia, prostate cancer and others. It is also engaged in the research, manufacture and sale of veterinary medicines such as combination drugs, chemical castration agents and others.

Employees

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
26-08-26	₩29,950.00	+0.84%	32,508
26-08-25	₩29,700.00	-0.67%	39,615
26-08-24	₩29,900.00	+5.10%	53,239
26-08-21	₩28,450.00	-5.95%	46,835
26-08-20	₩30,250.00	+0.50%	83,623

End-of-day quote Korea S.E.

More quotes

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

End-of-day quote Korea S.E. 2026-08-25			5-day change	1st Jan Change
29,700.00 ^KRW	-0.67%		-2.62%	-64.73%

1 day	-0.67%
1 week	-2.62%
Current month	+8.99%
1 month	+0.85%
3 months	-41.54%
6 months	-63.69%
Current year	-64.73%

1 week	27,800	33,550
1 month	22,650	34,650
Current year	22,650	101,700
1 year	22,650	101,700
3 years	9,400	101,700
5 years	8,440	101,700
10 years	8,440	101,700

Date	Insider	Type	Quantity	% Market Cap.
8/8/25	Dong Seok Park	Fiscal year	8,000	0.0796%
8/8/25	Se Yeon Kim	Fiscal year	10,000	0.0996%
8/8/25	Dong Seok Park	Fiscal year	8,000	0.0796%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
INVENTAGE LAB, INC.	-0.67%	-2.62%	-17.39%	+30.84%	285M
ELI LILLY AND COMPANY	-3.59%	-7.10%	+61.60%	+114.83%	1,100B
JOHNSON & JOHNSON	-1.15%	-1.25%	+52.98%	+62.41%	658B
ABBVIE INC.	-1.09%	-1.15%	+26.18%	+79.22%	470B
ROCHE HOLDING AG	-1.47%	+0.24%	+42.09%	+42.09%	372B
NOVARTIS AG	-0.90%	+0.05%	+25.57%	+41.75%	304B
ASTRAZENECA PLC	-1.94%	+1.53%	+3.05%	+13.24%	264B
AMGEN INC.	-0.43%	-0.46%	+52.06%	+71.75%	239B
NOVO NORDISK A/S	-0.93%	+1.84%	-13.11%	-52.28%	213B
GILEAD SCIENCES, INC.	-0.46%	+0.33%	+29.05%	+92.67%	184B
Average	-1.26%	+0.02%	+26.21%	+49.65%	380.32B
Weighted average by Cap.	-1.82%	-1.58%	+40.53%	+68.24%

Inventage Lab, Inc. Stock

Stocks

A389470

KR7389470006

Pharmaceuticals

Valuation: Inventage Lab, Inc.

Chart: Inventage Lab, Inc.

Latest news : Inventage Lab, Inc.

Quotes and Performance

Price Extremes

Managers and Directors: Inventage Lab, Inc.

Latest insider transactions

Other Pharmaceuticals

Financials

Company Profile

Quotes

	2024	2025
Net sales	1.78B 1.29M 1.1M 1.04M 946K 1.79M 123M 1.79M 12.26M 4.75M 61.87M 4.83M 4.72M 205M	2.94B 2.12M 1.82M 1.71M 1.56M 2.94M 202M 2.96M 20.21M 7.83M 102M 7.96M 7.79M 338M
Net income	-17B -12.26M -10.52M -9.88M -9.02M -17.02M -1.17B -17.1M -117M -45.29M -590M -46.03M -45.03M -1.95B	-8.46B -6.1M -5.24M -4.91M -4.49M -8.47M -582M -8.51M -58.16M -22.54M -294M -22.91M -22.41M -972M
Net Debt	-23.96B -17.28M -14.83M -13.92M -12.72M -24M -1.65B -24.12M -165M -63.86M -832M -64.9M -63.49M -2.75B	-5.33B -3.84M -3.3M -3.1M -2.83M -5.34M -366M -5.36M -36.63M -14.2M -185M -14.43M -14.11M -612M